|
GB767824A
(en)
|
1954-07-29 |
1957-02-06 |
Organon Labor Ltd |
Improvements in preparations for the treatment of the human skin
|
|
US3927216A
(en)
|
1971-06-01 |
1975-12-16 |
Icn Pharmaceuticals |
1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
|
|
US3921636A
(en)
|
1973-01-15 |
1975-11-25 |
Alza Corp |
Novel drug delivery device
|
|
US4107288A
(en)
|
1974-09-18 |
1978-08-15 |
Pharmaceutical Society Of Victoria |
Injectable compositions, nanoparticles useful therein, and process of manufacturing same
|
|
US4081533A
(en)
|
1976-09-01 |
1978-03-28 |
Regents Of The University Of California |
Method of reducing mammalian fertility and drugs therefor
|
|
US4391797A
(en)
|
1977-01-05 |
1983-07-05 |
The Children's Hospital Medical Center |
Systems for the controlled release of macromolecules
|
|
US4291028A
(en)
|
1977-12-30 |
1981-09-22 |
Nichols Vorys |
Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
|
|
US4292315A
(en)
|
1977-12-30 |
1981-09-29 |
Nichols Vorys |
Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
|
|
US4272398A
(en)
|
1978-08-17 |
1981-06-09 |
The United States Of America As Represented By The Secretary Of Agriculture |
Microencapsulation process
|
|
US4286587A
(en)
|
1978-10-11 |
1981-09-01 |
Alza Corporation |
Vaginal drug delivery system made from polymer
|
|
US4756907A
(en)
|
1978-10-17 |
1988-07-12 |
Stolle Research & Development Corp. |
Active/passive immunization of the internal female reproductive organs
|
|
DE3214667C2
(de)
|
1982-04-21 |
1985-07-18 |
Akzo Gmbh, 5600 Wuppertal |
Zusammengesetzter Körper für die Langzeitabgabe von Wirkstoffen
|
|
US4524359A
(en)
|
1982-07-23 |
1985-06-18 |
The United States Of America As Represented By The Secretary Of The Air Force |
Radar system for reducing angle tracking errors
|
|
US4588724A
(en)
|
1982-12-10 |
1986-05-13 |
Greenway Frank L Iii |
Treatment for selective reduction of regional fat deposits
|
|
US4673405A
(en)
|
1983-03-04 |
1987-06-16 |
Alza Corporation |
Osmotic system with instant drug availability
|
|
US4591496A
(en)
|
1984-01-16 |
1986-05-27 |
Massachusetts Institute Of Technology |
Process for making systems for the controlled release of macromolecules
|
|
FR2558373B1
(fr)
|
1984-01-20 |
1987-07-03 |
Mauvais Jarvis Pierre |
Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
|
|
NL8401912A
(nl)
|
1984-06-15 |
1986-01-02 |
Tno |
Met aktieve stof beladen biodegradeerbare polymeersubstraten, geschikt voor het gecontroleerd afgeven van de aktieve stof door middel van een membraan.
|
|
JPS6163615A
(ja)
*
|
1984-09-05 |
1986-04-01 |
Shunichi Naito |
消炎鎮痛剤
|
|
US4826830A
(en)
*
|
1985-07-31 |
1989-05-02 |
Jui Han |
Topical application of glyciphosphoramide
|
|
JPS62187415A
(ja)
*
|
1986-02-12 |
1987-08-15 |
Lion Corp |
経皮吸収促進用組成物
|
|
US4762717A
(en)
|
1986-03-21 |
1988-08-09 |
The General Hospital Corporation |
Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
|
|
US4919939A
(en)
|
1986-04-29 |
1990-04-24 |
Pharmetrix Corporation |
Periodontal disease treatment system
|
|
US5057317A
(en)
|
1987-03-24 |
1991-10-15 |
Chugai Seiyaku Kabushiki Kaisha |
Slow-release pharmaceutical agent
|
|
US4861627A
(en)
|
1987-05-01 |
1989-08-29 |
Massachusetts Institute Of Technology |
Preparation of multiwall polymeric microcapsules
|
|
US4873092A
(en)
|
1987-05-21 |
1989-10-10 |
Murata Kikai Kabushiki Kaisha |
Slow-releasing preparation
|
|
JP2590358B2
(ja)
|
1988-03-01 |
1997-03-12 |
正雄 五十嵐 |
子宮内膜症治療用の子宮内又は膣内投与製剤
|
|
US4945103A
(en)
|
1989-01-17 |
1990-07-31 |
Michael Cohen |
Method of treating pre-menstrual syndrome
|
|
IT1235053B
(it)
*
|
1989-04-07 |
1992-06-17 |
Poli Ind Chimica Spa |
Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti.
|
|
US5130137A
(en)
|
1989-08-09 |
1992-07-14 |
The General Hospital Corporation |
Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders
|
|
US5580857A
(en)
*
|
1989-12-12 |
1996-12-03 |
Oden; Per |
Use of gibberellins for the treatment of prostatitis
|
|
FR2663224B1
(fr)
|
1990-06-14 |
1995-01-20 |
Applicationes Farmaceuticas Sa |
Forme galenique parenterale.
|
|
US5091185A
(en)
|
1990-06-20 |
1992-02-25 |
Monsanto Company |
Coated veterinary implants
|
|
US5156851A
(en)
|
1990-06-20 |
1992-10-20 |
Monsanto Company |
Coated veterinary implants
|
|
FR2669537B1
(fr)
|
1990-11-28 |
1993-02-19 |
Oreal |
Composition amincissante a base d'alpha-2-bloqueurs.
|
|
US5552160A
(en)
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
AU1442592A
(en)
|
1991-02-20 |
1992-09-15 |
Nova Pharmaceutical Corporation |
Controlled release microparticulate delivery system for proteins
|
|
JPH0735335B2
(ja)
|
1991-02-28 |
1995-04-19 |
五十嵐 正雄 |
子宮内膜症の治療薬
|
|
US5340585A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Method and formulations for use in treating benign gynecological disorders
|
|
IT1250421B
(it)
|
1991-05-30 |
1995-04-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
|
|
HU222501B1
(hu)
|
1991-06-28 |
2003-07-28 |
Endorecherche Inc. |
MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
|
|
ZA924811B
(en)
|
1991-06-28 |
1993-12-29 |
Endorecherche Inc |
Controlled release systems and low dose androgens
|
|
US5330768A
(en)
|
1991-07-05 |
1994-07-19 |
Massachusetts Institute Of Technology |
Controlled drug delivery using polymer/pluronic blends
|
|
DE69224809T2
(de)
|
1991-12-30 |
1998-07-09 |
Akzo Nobel Nv |
Thyroaktive Zusammensetzung mit kontrollierter Freigabe
|
|
AU668384B2
(en)
|
1992-03-12 |
1996-05-02 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release ACTH containing microspheres
|
|
US5614212A
(en)
*
|
1992-04-08 |
1997-03-25 |
International Medical Associates, Inc. |
Method of transdermally administering high molecular weight drugs with a polymer skin enhancer
|
|
US5482706A
(en)
|
1992-04-17 |
1996-01-09 |
Takeda Chemical Industries, Ltd. |
Transmucosal therapeutic composition
|
|
CA2114968A1
(en)
*
|
1993-02-25 |
1994-08-26 |
John Wille |
Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
|
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
US5651976A
(en)
|
1993-06-17 |
1997-07-29 |
The United States Of America As Represented By The Secretary Of The Navy |
Controlled release of active agents using inorganic tubules
|
|
GB9318641D0
(en)
|
1993-09-08 |
1993-10-27 |
Edko Trading Representation |
Compositions
|
|
US5417982A
(en)
|
1994-02-17 |
1995-05-23 |
Modi; Pankaj |
Controlled release of drugs or hormones in biodegradable polymer microspheres
|
|
NL9400410A
(nl)
|
1994-03-16 |
1995-11-01 |
M D Ph D Willem Arthur Adriaan |
Intra-uterine anticonceptiemiddel.
|
|
US5482925A
(en)
|
1994-03-17 |
1996-01-09 |
Comedicus Incorporated |
Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
|
|
US5718388A
(en)
|
1994-05-25 |
1998-02-17 |
Eastman Kodak |
Continuous method of grinding pharmaceutical substances
|
|
TW384224B
(en)
|
1994-05-25 |
2000-03-11 |
Nano Sys Llc |
Method of preparing submicron particles of a therapeutic or diagnostic agent
|
|
US5587143A
(en)
|
1994-06-28 |
1996-12-24 |
Nanosystems L.L.C. |
Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanoparticle compositions
|
|
US5633011A
(en)
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
|
US5573783A
(en)
|
1995-02-13 |
1996-11-12 |
Nano Systems L.L.C. |
Redispersible nanoparticulate film matrices with protective overcoats
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
US5660835A
(en)
|
1995-02-24 |
1997-08-26 |
East Carolina University |
Method of treating adenosine depletion
|
|
US5536499A
(en)
|
1995-02-24 |
1996-07-16 |
Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. |
Cosmetic compositions for reducing or preventing signs of cellulite
|
|
ES2093562B1
(es)
|
1995-05-26 |
1997-07-01 |
Univ Santiago Compostela |
Estabilizacion de sistemas coloidales mediante formacion de complejos ionicos lipido-polisacarido.
|
|
US5705170A
(en)
|
1995-10-24 |
1998-01-06 |
Plantech International, Inc. |
Herbal cellulite treatments
|
|
US5789442A
(en)
|
1996-01-18 |
1998-08-04 |
Schering Aktiengesellschaft |
Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
|
|
AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
|
DE59703511D1
(de)
|
1996-03-29 |
2001-06-13 |
S W Patentverwaltungs Ges M B |
Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
|
|
US5778894A
(en)
|
1996-04-18 |
1998-07-14 |
Elizabeth Arden Co. |
Method for reducing human body cellulite by treatment with pulsed electromagnetic energy
|
|
JP2001502302A
(ja)
|
1996-09-19 |
2001-02-20 |
アメリカン・ホーム・プロダクツ・コーポレイション |
尿失禁を治療する方法
|
|
US6416778B1
(en)
*
|
1997-01-24 |
2002-07-09 |
Femmepharma |
Pharmaceutical preparations and methods for their regional administration
|
|
US5993856A
(en)
*
|
1997-01-24 |
1999-11-30 |
Femmepharma |
Pharmaceutical preparations and methods for their administration
|
|
US6071526A
(en)
|
1997-03-27 |
2000-06-06 |
S.W. Patentverwertungs Ges M.B. H. |
Cosmetic or cosmetic product for firming and soothing the skin in particular in the case of cellulite
|
|
US6319913B1
(en)
|
1997-11-10 |
2001-11-20 |
Cellegy Pharmaceuticals, Inc. |
Penetration enhancing and irritation reducing systems
|
|
DE19830732B4
(de)
*
|
1998-07-09 |
2008-11-13 |
Lts Lohmann Therapie-Systeme Ag |
Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung
|
|
ATE264093T1
(de)
*
|
1998-07-16 |
2004-04-15 |
Aaron Tabor |
Sojazubereitungen und deren verwendung zur gesundheitsförderung
|
|
SE9802864D0
(sv)
|
1998-08-27 |
1998-08-27 |
Pharmacia & Upjohn Ab |
Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
|
|
AU759016B2
(en)
|
1998-10-05 |
2003-04-03 |
Penn State Research Foundation, The |
Compositions and methods for enhancing receptor-mediated cellular internalization
|
|
JP2000143540A
(ja)
|
1998-11-06 |
2000-05-23 |
Bristol Myers Squibb Co |
非ステロイド系消炎鎮痛薬含有外用剤
|
|
AU5460800A
(en)
*
|
1999-06-02 |
2000-12-18 |
Aviana Biopharm |
Pharmaceutical transdermal compositions
|
|
US6358539B1
(en)
|
1999-08-20 |
2002-03-19 |
Howard Murad |
Pharmaceutical compositions for reducing the appearance of cellulite
|
|
WO2001019868A1
(en)
*
|
1999-09-15 |
2001-03-22 |
Mogam Biotechnology Research Institute |
A novel angiogenesis inhibitor
|
|
WO2001051089A1
(de)
*
|
2000-01-13 |
2001-07-19 |
Merck Patent Gmbh |
Pharmazeutische zubereitungen enthaltend 2-pyrrolidon als lösungsvermittler
|
|
US6436428B1
(en)
|
2000-03-21 |
2002-08-20 |
Enhance Pharmaceuticals, Inc. |
Device and method for treating urinary incontinence in females
|
|
JP2003531157A
(ja)
|
2000-04-26 |
2003-10-21 |
ワトソン ファーマシューティカルズ， インコーポレイテッド |
オキシブチニン治療に関連した有害な経験の最小化
|
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
|
DE10054294A1
(de)
|
2000-11-02 |
2002-05-16 |
Heinrich Wieland |
Topische Behandlung bei der Mastalgie
|
|
EP1249247B1
(en)
|
2001-03-30 |
2007-02-28 |
Chisso Corporation |
Pharmaceutical preparation for the treatment of gynecological diseases
|
|
DE10146541A1
(de)
|
2001-09-21 |
2003-04-17 |
Kade Pharma Fab Gmbh |
Arzneimittel auf Basis von Gestagenen zur dermalen Anwendung
|
|
WO2003028667A2
(en)
|
2001-10-04 |
2003-04-10 |
Cellegy Pharmaceuticals, Inc. |
Semisolid topical hormonal compositions and methods for treatment
|
|
JP2005512995A
(ja)
|
2001-11-09 |
2005-05-12 |
ファイザー ヘルス アーベー |
不安定又は過活動膀胱を治療するための抗ムスカリン剤及びエストロゲンアゴニスト
|
|
JP2005513080A
(ja)
|
2001-12-20 |
2005-05-12 |
フェムファーマ， インコーポレイテッド |
薬物の膣送達
|
|
US8476280B2
(en)
|
2002-05-09 |
2013-07-02 |
Versi Group, Llc |
Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
|
|
DE60327363D1
(de)
|
2002-12-18 |
2009-06-04 |
Besins Int Lab |
Verringerung der dichte des brustgewebes durch 4-hydroxy tamoxifen
|
|
MXPA05007266A
(es)
|
2003-01-02 |
2006-01-17 |
Femmepharma Holding Co Inc |
Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno.
|
|
US20050101579A1
(en)
|
2003-11-06 |
2005-05-12 |
Shippen Eugene R. |
Endometriosis treatment protocol
|
|
EP2104489A2
(en)
|
2006-12-26 |
2009-09-30 |
FemmePharma Holding Company, Inc. |
Topical administration of danazol
|
|
AU2008259864C1
(en)
|
2007-05-30 |
2014-03-06 |
Microdose Therapeutx, Inc. |
Methods and compositions for administration of Oxybutynin
|